2.5M XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 3,947 | 320,514 | - | 0.5 | 2,125 | Common Stock |
| Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 5,794 | 324,461 | - | 0.5 | 3,119 | Common Stock |
| Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 1,598 | 174,793 | - | 0.5 | 860 | Common Stock |
| Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 4,073 | 176,391 | - | 0.5 | 2,193 | Common Stock |
| Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 1,727 | 180,464 | - | 0.5 | 930 | Common Stock |
| Tomohiro Higa | SVP, Finance | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 1,017 | 101,155 | - | 0.5 | 548 | Common Stock |
| Tomohiro Higa | SVP, Finance | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 845 | 99,690 | - | 0.5 | 455 | Common Stock |
| Tomohiro Higa | SVP, Finance | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 10 Mar 2025 | 620 | 100,535 | - | 0.5 | 334 | Common Stock |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 05 Mar 2025 | 35,714,284 | 49,313,559 | - | 0.7 | 24,999,999 | Common Stock |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Mar 2025 | 17,857,142 | 17,857,142 | - | - | Series B Warrant (right to buy) | |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Mar 2025 | 35,714,284 | 35,714,284 | - | - | Series A Warrant (right to buy) | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 107,500 | 295,831 | - | 0 | Common Stock | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 401,390 | 401,390 | - | - | Stock Option (Right to Buy) | |
| Faraz Ali | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Feb 2025 | 401,390 | 0 | - | - | Stock Option (Right to Buy) | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 161,214 | 161,214 | - | - | Stock Option (Right to Buy) | |
| Faraz Ali | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Feb 2025 | 161,214 | 0 | - | - | Stock Option (Right to Buy) | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 353,271 | 353,271 | - | - | Stock Option (Right to Buy) | |
| Faraz Ali | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Feb 2025 | 353,271 | 0 | - | - | Stock Option (Right to Buy) | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 650,000 | 650,000 | - | - | Stock Option (Right to buy) | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 34,424 | 330,255 | - | 0 | Common Stock | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 40,000 | 147,106 | - | 0 | Common Stock | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 31,676 | 178,782 | - | 0 | Common Stock | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 235,000 | 235,000 | - | - | Stock Option (Right to buy) | |
| Whittemore Tingley | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jan 2025 | 69,982 | 0 | - | - | Stock Option (Right to Buy) | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 69,982 | 69,982 | - | - | Stock Option (Right to Buy) | |
| Whittemore Tingley | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jan 2025 | 141,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 141,000 | 141,000 | - | - | Stock Option (Right to Buy) | |
| Whittemore Tingley | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jan 2025 | 205,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 205,000 | 205,000 | - | - | Stock Option (Right to Buy) | |
| Whittemore Tingley | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jan 2025 | 215,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Chihiro Saito | SVP, Accounting and Fin. Ops. | Sale of securities on an exchange or to another person at price $ 2.12 per share. | 18 Nov 2024 | 2,258 | 60,983 | - | 2.1 | 4,787 | Common Stock |
| David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Jeffrey T. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Karah Parschauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Deepak Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to buy) | |
| Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 16 Aug 2024 | 3,946 | 188,331 | - | 2.9 | 11,422 | Common Stock |
| Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 16 Aug 2024 | 5,802 | 192,277 | - | 2.9 | 16,794 | Common Stock |
| Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 16 Aug 2024 | 5,803 | 108,731 | - | 2.9 | 16,797 | Common Stock |
| Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 16 Aug 2024 | 1,625 | 107,106 | - | 2.9 | 4,704 | Common Stock |
| Chihiro Saito | SVP, Accounting and Fin. Ops. | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 15 Aug 2024 | 807 | 63,241 | - | 2.9 | 2,336 | Common Stock |
| Chihiro Saito | SVP, Accounting and Fin. Ops. | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 15 Aug 2024 | 654 | 64,048 | - | 2.9 | 1,893 | Common Stock |
| Chihiro Saito | SVP, Accounting and Fin. Ops. | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 15 Aug 2024 | 902 | 64,702 | - | 2.9 | 2,611 | Common Stock |
| Chihiro Saito | SVP, Accounting and Fin. Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 25,000 | 65,604 | - | 0 | Common Stock | |
| Timothy Hoey | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 05 Mar 2024 | 3,300 | 245,346 | - | 7.0 | 23,101 | Common Stock |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 505,000 | 505,000 | - | - | Stock Option (Right to buy) | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 35,000 | 108,534 | - | 0 | Common Stock | |
| Timothy Hoey | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to buy) | |
| D Patterson Leone | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 35,000 | 95,755 | - | 0 | Common Stock | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 215,000 | 215,000 | - | - | Stock Option (Right to buy) | |
| Ali Faraz | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 85,000 | 198,079 | - | 0 | Common Stock | |
| Hoey Timothy | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 12,500 | 248,646 | - | 0 | Common Stock | |
| Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 205,000 | 205,000 | - | - | Stock Option (Right to buy) | |
| Timothy Hoey | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.16 per share. | 20 Feb 2024 | 200 | 236,146 | - | 6.2 | 1,233 | Common Stock |
| Hoey Timothy | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.31 per share. | 20 Feb 2024 | 6,369 | 236,346 | - | 5.3 | 33,813 | Common Stock |
| Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 16 Feb 2024 | 6,500 | 73,534 | - | 5.9 | 38,090 | Common Stock |
| Ali Faraz | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 16 Feb 2024 | 6,358 | 113,079 | - | 5.9 | 37,258 | Common Stock |
| Hoey Timothy | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 16 Feb 2024 | 4,681 | 242,715 | - | 5.9 | 27,431 | Common Stock |
| Leone Patterson D | Chief Fin. and Bus. Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 16 Feb 2024 | 5,201 | 60,755 | - | 5.9 | 30,478 | Common Stock |
| V. Goeddel David | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 12 Feb 2024 | 2,222,222 | 13,599,275 | - | 4.5 | 9,999,999 | Common Stock |
| Timothy Hoey | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.26 per share. | 29 Aug 2023 | 7,243 | 247,396 | - | 4.3 | 30,855 | Common Stock |
| Leone D Patterson | Chief Fin. and Bus. Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 16 Aug 2023 | 4,452 | 64,542 | - | 3.8 | 16,962 | Common Stock |
| Faraz Ali | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 16 Aug 2023 | 5,563 | 119,437 | - | 3.8 | 21,195 | Common Stock |
| Timothy Hoey | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 16 Aug 2023 | 4,007 | 254,639 | - | 3.8 | 15,267 | Common Stock |
| Whittemore Tingley | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 16 Aug 2023 | 5,563 | 76,437 | - | 3.8 | 21,195 | Common Stock |
| David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Jeffrey T. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Karah Parschauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Jin-Long Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 14,766 | 14,766 | - | - | Stock Option (Right to buy) | |
| Deepak Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 29,532 | 29,532 | - | - | Stock Option (Right to buy) | |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 10 Mar 2023 | 6,779 | 11,377,053 | - | 2.6 | 17,596 | Common Stock |
| Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 30,000 | 32,000 | - | 0 | Common Stock | |
| Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 190,000 | 190,000 | - | - | Stock Option (Right to buy) | |
| Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 35,000 | 67,000 | - | 0 | Common Stock | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 125,000 | 125,000 | - | 0 | Common Stock | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 675,000 | 675,000 | - | - | Stock Option (Right to buy) | |
| Timothy Hoey | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 175,000 | 175,000 | - | - | Stock Option (Right to buy) | |
| Timothy Hoey | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 30,000 | 228,646 | - | 0 | Common Stock | |
| Timothy Hoey | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 30,000 | 258,646 | - | 0 | Common Stock | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 35,000 | 35,000 | - | 0 | Common Stock | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 205,000 | 205,000 | - | - | Stock Option (Right to buy) | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 45,000 | 80,000 | - | 0 | Common Stock | |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 08 Feb 2023 | 1,500,000 | 11,370,274 | - | 2.6 | 3,900,000 | Common Stock |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 19 Jan 2023 | 69,739 | 9,870,274 | - | 2.5 | 174,201 | Common Stock |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.49 per share. | 17 Jan 2023 | 49,463 | 9,664,847 | - | 2.5 | 123,395 | Common Stock |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 17 Jan 2023 | 135,688 | 9,800,535 | - | 2.5 | 341,432 | Common Stock |
| Amy Burroughs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to buy) | |
| David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 21 Nov 2022 | 9,615,384 | 9,615,384 | - | 2.6 | 24,999,998 | Common Stock |
| Jin-Long Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| David V. Goeddel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Robert Sanders Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Jeffrey T. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Catherine Stehman-Breen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Deepak Srivastava | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Timothy Hoey | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.13 per share. | 26 Apr 2022 | 1,353 | 198,646 | - | 10.1 | 13,706 | Common Stock |
| Leone D. Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 66,000 | 66,000 | - | - | Stock Option (Right to buy) | |
| Faraz Ali | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 401,390 | 401,390 | - | - | Stock Option (Right to buy) | |
| Timothy Hoey | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 168,000 | 168,000 | - | - | Stock Option (Right to buy) | |
| Whittemore Tingley | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 141,000 | 141,000 | - | - | Stock Option (Right to buy) | |
| Karah Parschauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2021 | 19,495 | 19,495 | - | - | Stock Option (Right to Buy) | |
| June Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2021 | 18,937 | 18,937 | - | - | Stock Option (Right to Buy) | |
| David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 4,956,842 | 4,985,570 | - | 0 | Common Stock | ||
| David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 3,727,742 | 0 | - | - | Series A Preferred Stock | ||
| David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 4,209,755 | 0 | - | - | Series A Preferred Stock | ||
| David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 472,659 | 0 | - | - | Series B Preferred Stock | ||
| David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 533,781 | 0 | - | - | Series B Preferred Stock | ||
| David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 188,881 | 0 | - | - | Series C Preferred Stock | ||
| David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 4,389,282 | 4,414,720 | - | 0 | Common Stock | ||
| David V. Goeddel | Director, Ten Percent Owner | 03 Aug 2021 | 213,306 | 0 | - | - | Series C Preferred Stock | ||
| Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 361,969 | 0 | - | - | Series C Preferred Stock | ||
| Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 361,969 | 0 | - | - | Series C Preferred Stock | ||
| Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 2,012,880 | 0 | - | - | Series B Preferred Stock | ||
| Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 361,969 | 361,969 | - | 0 | Common Stock | ||
| Eli Casdin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Aug 2021 | 850,000 | 3,224,849 | - | 15 | 12,750,000 | Common Stock |
| Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 2,374,849 | 2,374,849 | - | 0 | Common Stock | ||
| JeenJoo Kang | Director | 03 Aug 2021 | 12,500 | 25,000 | - | 0 | Common Stock | ||
| JeenJoo Kang | Director | 03 Aug 2021 | 12,500 | 0 | - | - | Series A Preferred Stock |